Inflammatory cytokines in major depressive disorder: A case-control study

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Major depressive disorder (MDD) has a complex relationship with inflammation, with existing literature showing conflicting results.
• Previous studies may be limited by small sample sizes, lack of subject characterization, comorbidities, and a narrow focus on specific cytokines.

Purpose of the Study:

• To investigate the association between plasma cytokine levels and major depressive disorder in a well-characterized cohort.
• To address limitations in prior research by measuring a comprehensive panel of cytokines.

Main Methods:

• A cohort of 236 individuals diagnosed with MDD and matched healthy controls were evaluated.
• Plasma cytokine levels were measured using the MILLIPLEX Multi-Analyte Profiling Human Cytokine/Chemokine Assay with Luminex technology.
• Statistical analysis included the Wilcoxon rank-sum test with Bonferroni correction for multiple comparisons.

Main Results:

• No statistically significant differences in plasma cytokine levels were observed between the MDD group and controls.
• These findings remained consistent both before and after applying Bonferroni correction for multiple comparisons.

Conclusions:

• This study's findings do not support a link between major depressive disorder and systemic inflammation based on plasma cytokine levels.
• The heterogeneity of MDD and potential sampling bias towards non-inflammatory depression may explain discrepancies with previous literature.